'Deadly Risk' of Fat-Loss Drugs
Newsweek US|March 22, 2024
Diabetes treatment Ozempic has become popular among dieters due to its weightloss side effect, but a study warns of a link between the drug and suicidal thoughts
PANDORA DEWAN
'Deadly Risk' of Fat-Loss Drugs

"MIRACLE" FAT-MELTING DRUG OZEMPIC HAS been linked in a study to a series of rare but potentially fatal psychiatric episodes, scientists have warned.

The injectable prescription drug was developed to manage blood sugar levels in patients with Type 2 diabetes, but it has gained popularity and gone viral on social media due to one sought-after side effect: weight loss.

Ozempic is based on a naturally occurring human hormone called glucagon-like peptide 1, which plays an important role in regulating appetite and blood sugar levels. Its active ingredient is a molecule called semaglutide, which mimics the structure of this GLP-1 hormone and activates its receptors.

In doing so, semaglutide induces feelings of fullness while delaying the emptying of our stomach, making us less hungry and therefore less likely to overeat.

Semaglutide is also used in Ozempic's sister drug, Wegovy, which has been approved by the FDA for chronic weight management. Between the start of 2020 and the end of 2022, prescriptions of GLP-1 mimic medications like semaglutide increased by 300 percent across the U.S., according to health care analytics firm Trilliant Health.

The drug has since been endorsed by celebrities and influencers, with #ozempic reaching over 1.4 billion views on TikTok. However, when used as a weight-loss drug, semaglutide has been shown to have some uncomfortable side effects.

Most studies into these have focused on gut problems, but a new study, published in the International Journal of Clinical Pharmacy, has highlighted a concerning association between semaglutide and adverse psychiatric events, including depression, anxiety and suicidal thoughts. Pharmaceutical manufacturer Novo Nordisk, which produces Ozempic and Wegovy, cited the FDA saying that no evidence was found regarding suicidal thoughts or actions caused by these medicines.

Diese Geschichte stammt aus der March 22, 2024-Ausgabe von Newsweek US.

Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.

Diese Geschichte stammt aus der March 22, 2024-Ausgabe von Newsweek US.

Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.

WEITERE ARTIKEL AUS NEWSWEEK USAlle anzeigen
Most Loved Workplaces 2024
Newsweek US

Most Loved Workplaces 2024

A THE WORLD'S MOST LOVED WORKPLACES ARE REMARKABLE FOR A variety of reasons.

time-read
2 Minuten  |
May 31 - June 07, 2024 (Double Issue)
Maya Hawke
Newsweek US

Maya Hawke

MAYA HAWKE WEARS MANY HATS: ACTOR, WRITER, SINGER. BUT FOR Hawke, everything comes down to words.

time-read
2 Minuten  |
May 31 - June 07, 2024 (Double Issue)
Jacob Anderson
Newsweek US

Jacob Anderson

ANNE RICE'S NOVEL INTERVIEW WITH THE Vampire has a rabid fan base, intensely protective of the story and any adaptations of it.

time-read
2 Minuten  |
May 31 - June 07, 2024 (Double Issue)
VOTES OF NO CONFIDENCE
Newsweek US

VOTES OF NO CONFIDENCE

Why recent U.K. election results will ring alarm bells for Joe Biden

time-read
2 Minuten  |
May 31 - June 07, 2024 (Double Issue)
BIDEN'S BATTLEGROUND ELECTION
Newsweek US

BIDEN'S BATTLEGROUND ELECTION

A small number of Democrats PROTESTING the president's support for Israel's war in Gaza could PREVENT him from winning a second term

time-read
9 Minuten  |
May 31 - June 07, 2024 (Double Issue)
'It's Time to Treat Addiction Like Cancer'
Newsweek US

'It's Time to Treat Addiction Like Cancer'

Both are serious illnesses but, unlike those struggling with substance use disorders, didn’t face shame and stigma when seeking help over my tumors

time-read
4 Minuten  |
May 31 - June 07, 2024 (Double Issue)
Could Influencers Survive a Tik Tok Ban?
Newsweek US

Could Influencers Survive a Tik Tok Ban?

With some content creators able to make good money from views and brand collaborations on the app, losing access to it could come ata high price

time-read
3 Minuten  |
May 31 - June 07, 2024 (Double Issue)
All Welcome, Except Some
Newsweek US

All Welcome, Except Some

A Chinese foreign agent is behind an Asian American parade in New York City with Mayor Eric Adams, but not everyone is invited

time-read
5 Minuten  |
May 31 - June 07, 2024 (Double Issue)
America's Maternity Hospitals 2024
Newsweek US

America's Maternity Hospitals 2024

The arrival of a healthy baby brings unparalleled joy. It's no wonder that families welcoming their newest members are looking for high-quality health care to ensure a smooth delivery and reliable postpartum care.

time-read
3 Minuten  |
May 17, 2024
THE WEST SHOULD EXERT EVERY EFFORT TO MAKE RUSSIA PAY THE HIGHEST PRICE POSSIBLE FOR ITS AGGRESSIVE BEHAVIOR
Newsweek US

THE WEST SHOULD EXERT EVERY EFFORT TO MAKE RUSSIA PAY THE HIGHEST PRICE POSSIBLE FOR ITS AGGRESSIVE BEHAVIOR

RUSSIA'S FULL-SCALE INVASION of Ukraine in February 2022 awakened the worst memories for Georgians.

time-read
3 Minuten  |
May 24, 2024